What's the difference between Zepbound, Wegovy and Ozempic?
Our top 2 picks
Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.
Exceptional
Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery
Treatments offered
Compounded semaglutide injections (GLP-1), not FDA-approved · Compounded tirzepatide injections (dual GIP/GLP-1), not FDA-approved · Online intake and prescriber review by OpenLoop Health clinicians · Transfer at your current dose with proof of your existing prescription
Starting price
$49/month
*Compounded medications are not FDA-approved.
- Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
- Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
- Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
- No insurance required, no clinic visits; cancel at least 72 hours before the next billing date
from $49/month
Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required. Rated 3.8 across 10,689 Trustpilot reviews (Oct 25, 2026).
Read full embody reviewExcellent
Most Comprehensive GLP-1 Medication Access
Treatments offered
Compounded semaglutide (GLP-1) injection · Compounded tirzepatide (GLP-1 + GIP) injection · Brand-name Zepbound and Wegovy · One simple injection per week
Starting price
$199$89/month
*Compounded medications are not FDA-approved.
- Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
- Brand-name options too: Zepbound and Wegovy
- Clinician-guided - physician, PA, or nurse practitioner
- Free shipping (about 5-7 days)
from $89/month
Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.
Read full altRx reviewWhich is stronger - Zepbound or Wegovy?
On trial averages, Zepbound. Tirzepatide produced up to 22.5% average body-weight loss in its trials at the highest dose, versus roughly 15% for semaglutide in Wegovy's pivotal trial - a meaningful gap, with the usual honest caveats: averages hide individual variation, the drugs weren't compared head-to-head in those trials, and tolerability differs person to person.
Plenty of people respond excellently to semaglutide; some tolerate one and not the other. "Stronger on average" is true; "stronger for you" is what titration under a clinician discovers.
What do they cost out of pocket?
Shop GLP-1 plans by product
The lowest published plans - cheapest first, conditions under each price.
How do the side effects compare?
Same family, same character: GI effects dominate all three - nausea, constipation, diarrhea, especially during dose increases - because that's how this medication class works. Trial discontinuation rates were broadly similar, and the practical differences are individual: some people tolerate tirzepatide's dual mechanism better, some semaglutide.
Management is identical across them - slow titration, eating patterns, hydration - covered in our side-effects guide. Serious-but-rare warnings (pancreatitis, thyroid C-cell warnings) apply across the class.
What To Know Before Starting GLP-1 Treatment
Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.
GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.
That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Can you switch from Ozempic to Zepbound?
Yes, people do - and here's the part the search results get dangerously wrong: there is no mg-to-mg dose conversion between semaglutide and tirzepatide. They're different molecules with different dose ladders; a prescriber typically starts the new medication at or near its own starting dose and titrates from there, judging by response and tolerability.
Never attempt a DIY conversion. If the switch you actually want is away from brand pricing rather than between molecules, that's a different move - our switching-to-compounded guide covers it.
Which one should you choose?
Decision logic, honestly ordered. Chasing maximum average efficacy with budget for brand: Zepbound leads the trial numbers.
Insurance covering one of them: the covered one usually wins the math - check your formulary first. Self-pay: the compounded route's $59-$99/month changes the entire question, which is why it's our default starting point for cash payers - compare on the ranking.
Diabetes plus weight goals: that's an Ozempic/Mounjaro-label conversation with your clinician. Whichever route: prescription required, titration takes months, and the provider's follow-up quality matters more than the logo on the pen.








